Zymeworks ZYME Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -87.3%+92.3pp | -179.7%+1.9pp | -181.6%-213pp | 31.6%— | |
| Net margin | -76.6%+84.2pp | -160.8%-4.7pp | -156.1%-186pp | 30.1%— | |
| Returns | |||||
| Return on equity | -26.7%+3.8pp | -30.5%-5.8pp | -24.8%-58.3pp | 33.5%+97.8pp | |
| Return on invested capital | -34.5%+9.4pp | -43.9%+16.9pp | -60.8%-181pp | 120.1%— | |
| Efficiency | |||||
| Asset turnover | 0.3×+0.1× | 0.1×0.0× | 0.1×-0.7× | 0.8×— | |
| Liquidity | |||||
| Current ratio | 5.9×+2.5× | 3.4×-4.0× | 7.4×+1.7× | 5.7×+1.7× | |
| Leverage | |||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×-0.1× | |
| Per Share | |||||
| Book value per share | $3.56-20.3% | $4.46-33.9% | $6.75-10.7% | $7.56+58.1% | |
| Valuation | |||||
| Market capitalization | $1.99B+96.9% | $1.01B+85.7% | $543.09M+9.7% | $495.15M-35.1% | |
| Price / sales | 18.7×+5.5× | 13.2×+6.1× | 7.1×+5.9× | 1.2×— | |
| Price / book | 7.4×+4.4× | 3×+1.8× | 1.2×+0.2× | 1×-2.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Zymeworks's ratios come from?
- Every ratio is computed from Zymeworks's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
